Physician profile
Robert Kang Kwon
NPI 1215131099
$356.30
in general payments reported to CMS, 2019-2025
8 companies · $53.59 in 2025
The $53.59 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.05 · 2022: $64.79 · 2023: $91.74 · 2024: $60.13 · 2025: $53.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $111.81 | 2019-2024 | Integra, Biodrestore, Biodfactor |
| Smith+Nephew, INC. | $65.24 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System |
| Abbvie INC. | $59.43 | 2023 | |
| Pylant Medical | $51.10 | 2019-2022 | |
| Tela Bio, INC. | $24.73 | 2024 | Ovitex 2s |
| Sonex Health, INC. | $16.83 | 2023 | Sx-One Microknife |
| Polynovo North America LLC | $13.67 | 2025 | Novosorb Btm |
| Stryker Corporation | $13.49 | 2025 | Variax, Conextions Tr Tendon Repair System-Implant Mechanism, Asnis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.